Blue Ribbon Study Panel on Biodefense

#TheGreatAmericanTakeout Comes Back for Seconds

Retrieved on:

Tuesday, March 31, 2020

ResearchAndMarkets.com identifies Biodefense as one of the key industries seeing increased demand during the coronavirus pandemic.

Key Points:

ResearchAndMarkets.com identifies Biodefense as one of the key industries seeing increased demand during the coronavirus pandemic.
The coronavirus pandemic has highlighted the need for countries to be able to respond quickly to emerging biological threats.
The Biodefense sector will continue to play an important role in helping to control and contain the spread of the virus.
Some of the latest research in this area includes:

Biodefense Recognised as an Increasingly Important Area due to Ongoing Coronavirus Pandemic - ResearchAndMarkets.com

Retrieved on:

Tuesday, March 31, 2020

Infectious diseases, Biotechnology, Health, Articles, Biological warfare, Coronaviridae, Animal virology, Coronavirus, Biodefense, Pandemic, Blue Ribbon Study Panel on Biodefense

ResearchAndMarkets.com identifies Biodefense as one of the key industries seeing increased demand during the coronavirus pandemic.

Key Points:

ResearchAndMarkets.com identifies Biodefense as one of the key industries seeing increased demand during the coronavirus pandemic.
The coronavirus pandemic has highlighted the need for countries to be able to respond quickly to emerging biological threats.
The Biodefense sector will continue to play an important role in helping to control and contain the spread of the virus.
Some of the latest research in this area includes:

Biodefense Market Size, Analysis, Trends - Segmented by Product (Anthrax, Botulism, Smallpox, Nuclear) and Geography - Growth, Trends and Forecast (2019 - 2024)

Retrieved on:

Wednesday, September 11, 2019

Biological warfare, Bioethics, Biodefense, Life sciences, Biology, Medical specialties, Blue Ribbon Study Panel on Biodefense, National Biodefense Strategy Act

This act was designed to acquire medical countermeasures to biological, chemical, radiological, and nuclear agents for civilian use.

Key Points:

This act was designed to acquire medical countermeasures to biological, chemical, radiological, and nuclear agents for civilian use.
Though the implementation is observed slow, several recommendations and initiatives have been planned, particularly in the matured markets, such as North America.
For example, in 2015, 33 recommendations were given by the Blue Ribbon Study Panel, which could quickly act upon to improve the biodefense.
Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Best-Selling Author Max Brooks And Blue Ribbon Study Panel on Biodefense Provide A 'Very Graphic History' Of Germ Warfare

Retrieved on:

Thursday, April 25, 2019

Biological warfare, Bioethics, Bioterrorism, Blue Ribbon Study Panel on Biodefense, National security of the United States, Biodefense

WASHINGTON, April 25, 2019 /PRNewswire/ --Max Brooks, best-selling author of "World War Z" and non-resident fellow at the Modern War Institute at West Point, has partnered with the Blue Ribbon Study Panel on Biodefense to produce GERM WARFARE: A Very Graphic History.

Key Points:

WASHINGTON, April 25, 2019 /PRNewswire/ --Max Brooks, best-selling author of "World War Z" and non-resident fellow at the Modern War Institute at West Point, has partnered with the Blue Ribbon Study Panel on Biodefense to produce GERM WARFARE: A Very Graphic History.
"Germs have always been our greatest enemy, and now they're more dangerous than ever," said Brooks.
"At the very moment some people are questioning vaccines, others are looking for ways to cook up the next pandemic in their basements.
That's why I agreed to write this graphic novel for the Blue Ribbon Study Panel on Biodefense, because the experts can't help us if we don't help ourselves.